FOSAMAX® (ALENDRONATE) - Cuddy & Lanham

Fosamax®, is a bisphosphonate drug that is manufactured and marketed by the Merck pharmaceutical company. Fosamax® as a medication was commonly prescribed to patients for the treatment of osteoporosis and for the management of advanced cancers.

Unfortunately, this popular drug has been linked to the development of osteonecrosis of the jaw, or ONJ, a rare and serious condition that causes breakdown and death of the jaw bone. Osteonecrosis of the jaw typically develops after minor dental work, and because Fosamax® remains in the body for many months or years after treatment, even patients who are no longer using Fosamax® are at an increased risk for ONJ.

The drug was recently shown to have a higher incidence of ONJ than other bisphosphonates in a study conducted by the U.S. Food and Drug Administration. Evidence suggests that Merck failed to update the Fosamax® label to reflect the danger in a timely manner, exposing millions of users to unneccessary potential injury.

If you, or a family member, have taken Fosamax® and think that you or your family member may be suffering from its side effects, please call Lanham & Blackwell, P.A., for assistance and more information. Our experience in these types of cases can help you in protecting your legal rights and holding negligent parties responsible.


		FOSAMAX (ALENDRONATE) Fosamax®, is a bisphosphonate drug that is manufactured and marketed by the Merck pharmaceutical company. Fosamax® as a medication was commonly prescribed to patients for the treatment of osteoporosis and for the management of advanced cancers. Unfortunately, this popular drug has been linked to the development of osteonecrosis of the jaw, or ONJ, a rare and serious condition that causes breakdown and death of the jaw bone. Osteonecrosis of the jaw typically develops after minor dental work, and because Fosamax® remains in the body for many months or years after treatment, even patients who are no longer using Fosamax® are at an increased risk for ONJ. The drug was recently shown to have a higher incidence of ONJ than other bisphosphonates in a study conducted by the U.S. Food and Drug Administration. Evidence suggests that Merck failed to update the Fosamax® label to reflect the danger in a timely manner, exposing millions of users to unneccessary potential injury. If you, or a family member, have taken Fosamax® and think that you or your family member may be suffering from its side effects, please call Lanham & Blackwell, P.A., for assistance and more information. Our experience in these types of cases can help you in protecting your legal rights and holding negligent parties responsible. Contact Us
		©2006 Lanham & Blackwell, P.A. All rights reserved. Site Map Legal Disclaimer